Related Experiment Videos
[Autoimmune hemolytic anemia complicating homozygotic beta- thalassemia]
Archives Francaises De Pediatrie
|April 1, 1986
Insights
Auto-immune hemolytic anemia can occur in children with beta-thalassemia. Corticosteroid treatment proved effective, leading to negative Coombs tests in most cases.
Area of Science:
- Hematology
- Pediatrics
- Immunology
Background:
- Beta-thalassemia is a group of inherited blood disorders.
- Auto-immune hemolytic anemia (AIHA) is a rare complication.
Observation:
- Four pediatric cases of AIHA in intermediate or major beta-thalassemia were observed.
- Patients ranged from 2 to 13 years old; two had prior splenectomy.
- Positive direct Coombs tests indicated IgG and/or complement involvement.
Findings:
- Corticosteroid therapy was administered to three children.
- Beneficial responses were noted, with negative Coombs tests achieved.
- Resolution times varied from 15 days to 8 months.
Implications:
- Corticosteroids represent a viable treatment for AIHA in pediatric beta-thalassemia.
- Early diagnosis and management can improve patient outcomes.
- Further research into the mechanisms and optimal treatment strategies is warranted.
Abstract:
Four cases of auto-immune hemolytic anemia complicating the course of intermediate or major beta-thalassemia syndromes are reported in children. Ages ranged from 2 to 13 years. Two children had undergone a splenectomy. The direct Coombs test was positive of the IgG +/- complement or complement alone type. Corticosteroid therapy was beneficial in the 3 children who were given this treatment. Coombs test became negative after intervals ranging from 15 days to 8 months.